How opioids inhibit GABA-mediated neurotransmission

C. W. Vaughan, S. L. Ingram, M. A. Connor, M. J. Christie

Research output: Contribution to journalArticlepeer-review

437 Scopus citations


The midbrain region periaqueductal grey (PAG) is rich in opioid receptors and endogenous opioids and is a major target of analgesic action in the central nervous system. It has been proposed that the analgesic effect of opioids on the PAG works by suppressing the inhibitory influence of the neurotransmitter GABA (γ-aminobutyric acid) on neurons that form part of a descending antinociceptive pathway. Opioids inhibit GABA-mediated (GABAergic) synaptic transmission in the PAG and other brain regions by reducing the probability of presynaptic neurotransmitter release, but the mechanisms involved remain uncertain. Here we report that opioid inhibition of GABAergic synaptic currents in the PAG is controlled by a presynaptic voltage-dependent potassium conductance. Opioid receptors of the μ type in GABAergic presynaptic terminals are specifically coupled to this potassium conductance by a pathway involving phospholipase A2, arachidonic acid and 12- lipoxygenase. Furthermore, opioid inhibition of GABAergic synaptic transmission is potentiated by inhibitors of the enzymes cyclooxygenase and 5-lipoxygenase, presumably because more arachidonic acid is available for conversion to 12-lipoxygenase products. These mechanisms account for the analgesic action of cyclooxygenase inhibitors in the PAG and their synergism with opioids.

Original languageEnglish (US)
Pages (from-to)611-614
Number of pages4
Issue number6660
StatePublished - 1997
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'How opioids inhibit GABA-mediated neurotransmission'. Together they form a unique fingerprint.

Cite this